+ All Categories
Home > Documents > Acute Leukemia Lecture

Acute Leukemia Lecture

Date post: 07-Jul-2018
Category:
Upload: mohammed-shaik
View: 226 times
Download: 0 times
Share this document with a friend

of 21

Transcript
  • 8/18/2019 Acute Leukemia Lecture

    1/21

  • 8/18/2019 Acute Leukemia Lecture

    2/21

  • 8/18/2019 Acute Leukemia Lecture

    3/21

    AM

    • Aetiology: unclear association with

    pre !e"isting myelodiplasia or

    pri#ious chemotherapyradiation therapy

    $en%ene e"posure

    &own sy

  • 8/18/2019 Acute Leukemia Lecture

    4/21

  • 8/18/2019 Acute Leukemia Lecture

    5/21

  • 8/18/2019 Acute Leukemia Lecture

    6/21

    AM

    • Morphological classi'cation

    • renchAmerican$ritish system is based onthe degree of di-erentiation ! is a

    morphological classi'cation• ,ytochemistry is based on

     – udan black stain

     – Myelopero"idase stain

     hese stains are positi#e in AM and negati#e A

    2on speci'c esterase is positi#e monocyticsubtype

  • 8/18/2019 Acute Leukemia Lecture

    7/21

    AM

    • 45 classi'cation correlatesmorphological genetic and clinicalfeature

    • In this classi'cation the blastthreshold for the diagnosis AM is)/(*0+ blasts

  • 8/18/2019 Acute Leukemia Lecture

    8/21

  • 8/18/2019 Acute Leukemia Lecture

    9/21

    AM

    • Immunophenotyping ! monoclonal antibody tocell surface antigen di-erentiate AM from A

    • ineage in'delity: in some situation thee"pression of markers of more than one cellularlineage

    • $iphenotypic leukemia

    • ,ytogenetic analysis should be always

    performed7 there are 3 groups – a#ourable reisk

     – Intermediate risk

     – 8oor risk

  • 8/18/2019 Acute Leukemia Lecture

    10/21

    AM

    • Molecular analysis 9uorescence insitu hybridisation I4 and re#ersetranscriptase chain reaction !

    8, 7 add sensiti#ity and precisionthe detection of translocationdeletions and aneoplodity in case

    when cytogeenetics fails or gi#esnormal results

  • 8/18/2019 Acute Leukemia Lecture

    11/21

    AM

    • ,linical features

    • Acute presentation is usual oftencritically ill due to bone marrowfailure

    • ymptoms of anemia: weakness 7letargy7 breathlessnesslightheadedness and palpitation

    • Infections: chest7 mouth7 perianal7skin staphylococcus7 8seudomonas7

    ,andida

  • 8/18/2019 Acute Leukemia Lecture

    12/21

  • 8/18/2019 Acute Leukemia Lecture

    13/21

    AM

    • In#estigation and diagnosis

    • I4 and blood 'lm

    • $one marrow aspirate and biopsy

    • $one marrow cytogenetics

    • Immunophenotyping of bone marrowblasts or blood blasts

    •  otal $, usually increased with blastson blood 'lm but $, may be low

    • 4$7 neurophils and platelets low

  • 8/18/2019 Acute Leukemia Lecture

    14/21

  • 8/18/2019 Acute Leukemia Lecture

    15/21

    AM

    • upporti#e treatment

    • ;ood communication with patientand family

    •  ransfusion platelet and $,

    • 2eutropenic treatment

    4ydration Allopurinol for pre#entinghypercalcemia

    • ,entral #enous catheter

  • 8/18/2019 Acute Leukemia Lecture

    16/21

  • 8/18/2019 Acute Leukemia Lecture

    17/21

    AM

    • eukemia is not detected bycon#entional morphological methodsbut may be demonstrated by more

    sensiti#e molecular techniue

    • , is not synonymous with cure

  • 8/18/2019 Acute Leukemia Lecture

    18/21

    AM

    •  reatment has 3 phases

    • emission inductionusually 1* courses ofcombination ,

    • ,onsolidation therapy to reduce leukemiaburden further and reduce the risk ofrelapse

    • 5ptimum no of cycles *< with autologus or

    allogenic sstem cell transplantation

    • Maintenance therapy only when intensi#econsolidation can not be tolerated

  • 8/18/2019 Acute Leukemia Lecture

    19/21

    AM

    • 8rognosis

    • 60B0+ of pts aged > C0 will achie#e,

    • elapse risk of pts 7 C0 withfa#ourable risk cytogentics is *@

  • 8/18/2019 Acute Leukemia Lecture

    20/21

    AM

    • 8rognosis

    • Age group >C0

    eucocytic count at the presentation>*?"10@/ is fa#ourablre but when)100"10@/ is unfa#ourable

    • 4istory od pre#ious mielodisplasia

    •  some A$ subtype has fa#ourableprognosis

  • 8/18/2019 Acute Leukemia Lecture

    21/21


Recommended